Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

A blood pressure drug, diltiazem, may also help treat influenza.

The ShorT method can detect and help reduce bias in medical AI by identifying shortcut learning.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

A young tapir with a rare skin condition improved after treatment with wound cleaning, cream, and oral medication.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Hair care products often cause allergic skin reactions, so testing and new treatments are important.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The photographic method for measuring facial hair density is reliable and valid but needs further testing on different hair densities and skin colors.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The study created a skin model with realistic blood vessels that improves skin grafts and testing for drug delivery.